*Pharma Majors Bet Big on OTC Boom – Here’s Why* Despite health concerns, the surge in OTC drug demand is driving pharma giants to diversify revenue streams. With skincare and personal health trends on the rise, dermatological products are now more accessible than ever. From D2C disruptors to industry leaders, everyone wants a piece of the pie. *🔎 Get the full story and more with an exclusive subscription!* *https://bit.ly/3RvolPp*